Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakano, S.
Right arrow Articles by Kimura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakano, S.
Right arrow Articles by Kimura, J.
Neurology 1999;53:1671
© 1999 American Academy of Neurology
Articles

Aberrant expression of cyclin-dependent kinase 5 in inclusion body myositis

S. Nakano, MD, I. Akiguchi, MD, S. Nakamura, MD, H. Satoi, MD, S. Kawashima, MD and J. Kimura, MD

From the Department of Neurology, Faculty of Medicine, Kyoto University, Japan.

Address correspondence and reprint requests to Dr. Satoshi Nakano, Department of Neurology, Faculty of Medicine, Kyoto University, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606-8507 Japan; e-mail: snakano{at}isola.kuhp.kyoto-u.ac.jp

OBJECTIVE: To investigate abnormal protein expression in inclusion body myositis (IBM).

BACKGROUND: In IBM, ectopic deposition of ß-amyloid protein as well as several other proteins in some muscle fibers occurs. Some, but not all, of these proteins are also expressed in myofibrillar myopathy (MFM). The authors recently reported aberrant expressions of several cyclin-dependent kinases (CDKs)—enzymes regulating the cell replication cycle—in MFM. They therefore tested the notion that aberrant expression of CDKs also occurs in IBM. Among CDKs, CDK1, CDK2, and CDK5 have been demonstrated to phosphorylate tau, which is a component of inclusions in IBM. CDK5 appears in a stage of myogenesis when CDK1 and CDK2 are downregulated.

METHODS: Cryostat sections of muscle specimens from 10 patients with sporadic IBM were immunostained for CDK1, CDK2, and CDK5. Fourteen patients with polymyositis and eight individuals with dermatomyositis served as disease control subjects.

RESULTS: In IBM, numerous CDK5-positive inclusions were present in vacuolated fibers. CDK5 expression was not observed in any disease control subject. Regenerating fibers expressed CDK1 and CDK2 in all diseases.

CONCLUSION: The results suggest that cyclin-dependent kinases (CDK)5, but no other CDKs, is involved in the formation of inclusions in IBM.

Key words: Inclusion body myositis—Cyclin-dependent kinase—CDK5—Phosphorylation—Immunohistochemistry.




This article has been cited by other articles:


Home page
 BMJHome page
S. A Greenberg
How citation distortions create unfounded authority: analysis of a citation network
BMJ, July 23, 2009; 339(jul20_3): b2680 - b2680.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Kitazawa, K. N. Green, A. Caccamo, and F. M. LaFerla
Genetically Augmenting A{beta}42 Levels in Skeletal Muscle Exacerbates Inclusion Body Myositis-Like Pathology and Motor Deficits in Transgenic Mice
Am. J. Pathol., June 1, 2006; 168(6): 1986 - 1997.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Nakano, A. Shinde, H. Ito, H. Ito, and H. Kusaka
Messenger RNA degradation may be inhibited in sporadic inclusion body myositis
Neurology, August 9, 2005; 65(3): 420 - 425.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Nakano, A. Shinde, S. Kawashima, S. Nakamura, I. Akiguchi, and J. Kimura
Inclusion body myositis: Expression of extracellular signal-regulated kinase and its substrate
Neurology, January 9, 2001; 56(1): 87 - 93.
[Abstract] [Full Text] [PDF]